Sep 19

We all know generics are cheaper. But how much cheaper? Economists find a 38 to 48 percent decline in the prices of physician-administered drugs after the drugs' patents have expired. The decline is slightly lower for oral drugs.

This May, Colorado's governor signed the nation's first "right to try" bill, which allows terminally ill patients to try unapproved — and potentially dangerous — drugs outside of clinical trials and without approval from federal regulators.

The Latest